Company · CIK 0000059478 · SIC 2834 — Pharmaceutical Preparations · NYSE
ELI LILLY & Co · LLY
Insider activity reported against this company. All insider holders · Files at: SCTX, ELAN, ZYME, CYPH, CLCD, SYRE, ZSAN. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2015 FMForm 4 → | Feb 3, 3:58 pm EST | John C LechleiterChairman, President and CEO, Director | 77,130 | $72.00 | $1,776,096 | 662,416 | — | plan? |
| Feb 1, 2015 FMForm 4 → | Feb 3, 3:56 pm EST | Stephen F FrySVP, HR & Diversity | 12,341 | $72.00 | $284,184 | 67,610 | — | plan? |
| Feb 1, 2015 FMForm 4 → | Feb 3, 3:53 pm EST | Maria A CrowePresident, Mfg. Operations | 13,241 | $72.00 | $298,584 | 62,745 | — | plan? |
| Feb 1, 2015 FMForm 4 → | Feb 3, 3:50 pm EST | Enrique A ConternoSr. VP & Pres., Lilly Diabetes | 20,598 | $72.00 | $475,776 | 111,782 | — | plan? |
| Jan 30, 2015 AForm 4 → | Jan 30, 5:53 pm EST | Ralph AlvarezDirector | 138 | $72.03 | $9,940 | 26,712 | — | plan? |
| Jan 28, 2015 AForm 4 → | Jan 30, 5:50 pm EST | Alfonso G ZuluetaSVP& Pres., Emerging Markets | 11,532 | $70.97 | $818,426 | 52,692 | — | plan? |
| Jan 28, 2015 AForm 4 → | Jan 30, 5:48 pm EST | Donald A ZakrowskiChief Accounting Officer | 1,373 | $70.97 | $97,442 | 4,420 | — | plan? |
| Jan 28, 2015 AForm 4 → | Jan 30, 5:47 pm EST | Fionnuala M WalshSVP, Global Quality | 20,904 | $70.97 | $1,483,557 | 22,578 | — | plan? |
| Jan 28, 2015 AForm 4 → | Jan 30, 5:45 pm EST | Jeffrey N SimmonsSVP&Pres. Elanco Animal Health | 27,653 | $70.97 | $1,962,533 | 107,089 | — | plan? |
| Jan 28, 2015 AForm 4 → | Jan 30, 5:42 pm EST | David A RicksSVP and Pres, Lilly Bio-Meds | 27,248 | $70.97 | $1,933,791 | 61,403 | — | plan? |
| Jan 28, 2015 AForm 4 → | Jan 30, 5:40 pm EST | Derica W RiceEVP-Global Services and CFO | 56,158 | $70.97 | $3,985,533 | 56,158 | — | plan? |
| Jan 28, 2015 AForm 4 → | Jan 30, 5:38 pm EST | Barton R PetersonSr. VP, Corp. Affairs & Comm. | 16,051 | $70.97 | $1,139,139 | 75,700 | — | plan? |
| Jan 28, 2015 AForm 4 → | Jan 30, 5:36 pm EST | Susan MahonySVP & Pres., Lilly Oncology | 28,461 | $70.97 | $2,019,877 | 8,984 | — | plan? |
| Jan 28, 2015 AForm 4 → | Jan 30, 5:24 pm EST | Jan M LundbergEVP,Science&Tech and Pres. LRL | 44,073 | $70.97 | $3,127,861 | 199,131 | — | plan? |
| Jan 28, 2015 AForm 4 → | Jan 30, 5:22 pm EST | John C LechleiterChairman, President and CEO, Director | 107,344 | $70.97 | $7,618,204 | 634,622 | — | plan? |
| Jan 28, 2015 AForm 4 → | Jan 30, 5:21 pm EST | Michael J HarringtonSenior VP and General Counsel | 7,466 | $70.97 | $529,862 | 38,518 | — | plan? |
| Jan 28, 2015 AForm 4 → | Jan 30, 5:18 pm EST | Stephen F FrySVP, HR & Diversity | 18,855 | $70.97 | $1,338,139 | 63,163 | — | plan? |
| Jan 28, 2015 AForm 4 → | Jan 30, 5:16 pm EST | Maria A CrowePresident, Mfg. Operations | 20,753 | $70.97 | $1,472,840 | 57,798 | — | plan? |
| Jan 28, 2015 AForm 4 → | Jan 30, 5:12 pm EST | Enrique A ConternoSr. VP & Pres., Lilly Diabetes | 30,037 | $70.97 | $2,131,726 | 104,400 | — | plan? |
| Jan 28, 2015 AForm 4 → | Jan 30, 5:10 pm EST | Melissa S BarnesChief Eth/Cmpl Ofcr & SVP, ERM | 2,943 | $70.97 | $208,865 | 6,587 | — | plan? |
| Dec 31, 2014 AForm 4 → | Jan 5, 2015, 11:48 am EST | Ralph AlvarezDirector | 123 | $69.67 | $8,569 | 26,574 | — | plan? |
| Dec 4, 2014 GForm 5 → | Feb 4, 2015, 1:58 pm EST | Susan MahonySVP & Pres., Lilly Oncology | 730 | — | — | 86,757 | — | plan? |
| Sep 15, 2014 GForm 5 → | Jan 29, 2015, 1:31 pm EST | Derica W RiceEVP-Global Services and CFO | 53,498 | — | — | 278,263 | — | plan? |
| Jun 12, 2014 GForm 5 → | Jan 29, 2015, 1:26 pm EST | John C LechleiterChairman, President and CEO, Director | 4,245 | — | — | 49,102 | — | plan? |
| Apr 29, 2014 GForm 5 → | Jan 29, 2015, 1:33 pm EST | David A RicksSVP and Pres, Lilly Bio-Meds | 85 | — | — | 34,155 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 26, 2016 AForm 4 → | Jan 28, 6:49 pm EST | Fionnuala M WalshSVP, Global Quality | 4,610 | — | — | 4,610 | — | |
| Jan 26, 2016 AForm 4 → | Jan 28, 6:48 pm EST | Stephen F FrySVP, HR & Diversity | 7,683 | — | — | 7,683 | — | |
| Jan 26, 2016 AForm 4 → | Jan 28, 6:47 pm EST | Jan M LundbergEVP,Science&Tech and Pres. LRL | 15,366 | — | — | 15,366 | — | |
| Jan 26, 2016 AForm 4 → | Jan 28, 6:46 pm EST | Jeffrey N SimmonsSVP&Pres. Elanco Animal Health | 10,244 | — | — | 10,244 | — | |
| Jan 26, 2016 AForm 4 → | Jan 28, 6:45 pm EST | Enrique A ConternoSr. VP & Pres., Lilly Diabetes | 10,244 | — | — | 10,244 | — | |
| Jan 26, 2016 AForm 4 → | Jan 28, 6:43 pm EST | Barton R PetersonSr. VP, Corp. Affairs & Comm. | 5,634 | — | — | 5,634 | — | |
| Jan 26, 2016 AForm 4 → | Jan 28, 6:42 pm EST | Susan MahonySVP & Pres., Lilly Oncology | 9,732 | — | — | 9,732 | — | |
| Jan 26, 2016 AForm 4 → | Jan 28, 6:41 pm EST | Derica W RiceEVP-Global Services and CFO | 19,463 | — | — | 19,463 | — | |
| Jan 26, 2016 AForm 4 → | Jan 28, 6:40 pm EST | John C LechleiterChairman, President and CEO, Director | 46,097 | — | — | 46,097 | — | |
| Nov 23, 2015 MForm 4 → | Nov 25, 2:57 pm EST | Fionnuala M WalshSVP, Global Quality | 9,036 | — | — | 0 | — | |
| Nov 20, 2015 MForm 4 → | Nov 23, 3:45 pm EST | Alfonso G ZuluetaSVP& Pres., Emerging Markets | 12,048 | — | — | 0 | — | |
| Nov 12, 2015 MForm 4 → | Nov 16, 3:51 pm EST | Enrique A ConternoSr. VP & Pres., Lilly Diabetes | 6,928 | — | — | 0 | — | |
| Nov 5, 2015 MForm 4 → | Nov 9, 4:33 pm EST | David A RicksSVP and Pres, Lilly Bio-Meds | 4,970 | — | — | 0 | — | amended |
| Nov 3, 2015 MForm 4 → | Nov 5, 1:53 pm EST | John C LechleiterChairman, President and CEO, Director | 70,964 | — | — | 0 | — | |
| May 5, 2015 MForm 4 → | May 7, 3:08 pm EDT | Maria A CrowePresident, Mfg. Operations | 6,024 | — | — | 0 | — | |
| May 5, 2015 MForm 4 → | May 7, 3:07 pm EDT | Derica W RiceEVP-Global Services and CFO | 57,108 | — | — | 0 | — | |
| Apr 28, 2015 MForm 4 → | Apr 30, 1:30 pm EDT | Michael J HarringtonSenior VP and General Counsel | 6,024 | — | — | 0 | — | |
| Apr 28, 2015 MForm 4 → | Apr 30, 1:28 pm EDT | John C LechleiterChairman, President and CEO, Director | 70,000 | — | — | 70,964 | — | |
| Feb 11, 2015 MForm 4 → | Feb 12, 4:53 pm EST | Susan MahonySVP & Pres., Lilly Oncology | 9,036 | — | — | 0 | — | |
| Feb 1, 2015 MForm 4 → | Feb 3, 4:13 pm EST | Fionnuala M WalshSVP, Global Quality | 5,246 | — | — | 0 | — | |
| Feb 1, 2015 MForm 4 → | Feb 3, 4:11 pm EST | Jeffrey N SimmonsSVP&Pres. Elanco Animal Health | 12,591 | — | — | 0 | — | |
| Feb 1, 2015 MForm 4 → | Feb 3, 4:08 pm EST | David A RicksSVP and Pres, Lilly Bio-Meds | 12,591 | — | — | 0 | — | |
| Feb 1, 2015 MForm 4 → | Feb 3, 4:06 pm EST | Derica W RiceEVP-Global Services and CFO | 26,581 | — | — | 0 | — | |
| Feb 1, 2015 MForm 4 → | Feb 3, 4:04 pm EST | Barton R PetersonSr. VP, Corp. Affairs & Comm. | 6,995 | — | — | 0 | — | |
| Feb 1, 2015 MForm 4 → | Feb 3, 4:01 pm EST | Susan MahonySVP & Pres., Lilly Oncology | 12,591 | — | — | 0 | — | |
| Feb 1, 2015 MForm 4 → | Feb 3, 3:59 pm EST | Jan M LundbergEVP,Science&Tech and Pres. LRL | 20,985 | — | — | 0 | — | |
| Feb 1, 2015 MForm 4 → | Feb 3, 3:58 pm EST | John C LechleiterChairman, President and CEO, Director | 52,462 | — | — | 0 | — | |
| Feb 1, 2015 MForm 4 → | Feb 3, 3:56 pm EST | Stephen F FrySVP, HR & Diversity | 8,394 | — | — | 0 | — | |
| Feb 1, 2015 MForm 4 → | Feb 3, 3:53 pm EST | Maria A CrowePresident, Mfg. Operations | 9,094 | — | — | 0 | — | |
| Feb 1, 2015 MForm 4 → | Feb 3, 3:50 pm EST | Enrique A ConternoSr. VP & Pres., Lilly Diabetes | 13,990 | — | — | 0 | — | |
| Jan 28, 2015 AForm 4 → | Jan 30, 5:47 pm EST | Fionnuala M WalshSVP, Global Quality | 4,144 | — | — | 4,144 | — | |
| Jan 28, 2015 AForm 4 → | Jan 30, 5:45 pm EST | Jeffrey N SimmonsSVP&Pres. Elanco Animal Health | 9,843 | — | — | 9,843 | — | |
| Jan 28, 2015 AForm 4 → | Jan 30, 5:42 pm EST | David A RicksSVP and Pres, Lilly Bio-Meds | 9,843 | — | — | 9,843 | — | |
| Jan 28, 2015 AForm 4 → | Jan 30, 5:40 pm EST | Derica W RiceEVP-Global Services and CFO | 19,685 | — | — | 19,685 | — | |
| Jan 28, 2015 AForm 4 → | Jan 30, 5:38 pm EST | Barton R PetersonSr. VP, Corp. Affairs & Comm. | 5,698 | — | — | 5,698 | — | |
| Jan 28, 2015 AForm 4 → | Jan 30, 5:36 pm EST | Susan MahonySVP & Pres., Lilly Oncology | 9,843 | — | — | 9,843 | — | |
| Jan 28, 2015 AForm 4 → | Jan 30, 5:24 pm EST | Jan M LundbergEVP,Science&Tech and Pres. LRL | 15,541 | — | — | 15,541 | — | |
| Jan 28, 2015 AForm 4 → | Jan 30, 5:22 pm EST | John C LechleiterChairman, President and CEO, Director | 46,623 | — | — | 46,623 | — | |
| Jan 28, 2015 AForm 4 → | Jan 30, 5:21 pm EST | Michael J HarringtonSenior VP and General Counsel | 9,066 | — | — | 9,066 | — | |
| Jan 28, 2015 AForm 4 → | Jan 30, 5:18 pm EST | Stephen F FrySVP, HR & Diversity | 7,252 | — | — | 7,252 | — | |
| Jan 28, 2015 AForm 4 → | Jan 30, 5:16 pm EST | Maria A CrowePresident, Mfg. Operations | 7,252 | — | — | 7,252 | — | |
| Jan 28, 2015 AForm 4 → | Jan 30, 5:12 pm EST | Enrique A ConternoSr. VP & Pres., Lilly Diabetes | 10,360 | — | — | 10,360 | — | |
| Jan 28, 2015 AForm 4 → | Jan 30, 5:10 pm EST | Melissa S BarnesChief Eth/Cmpl Ofcr & SVP, ERM | 2,072 | — | — | 2,072 | — |
Filed by this entity as an insider elsewhere — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2019 DForm 4 → | Mar 11, 8:03 am EDT | Elanco Animal Health IncELAN | 293,290,000 | — | — | 0 | — | plan? |
| Jan 31, 2019 SForm 4 → | Feb 4, 4:36 pm EST | Zymeworks Inc.ZYME | 250,000 | $16.00 | $4,000,000 | 2,898,647 | −7.94% | plan? amended |
| Nov 6, 2018 SForm 4 → | Nov 8, 11:34 am EST | Zymeworks Inc.ZYME | 700,000 | $14.00 | $9,800,000 | 3,148,647 | −18.2% | plan? |
| Sep 24, 2018 SForm 4 → | Sep 26, 2:50 pm EDT | Zymeworks Inc.ZYME | 2,027 | $16.36 | $33,162 | 3,848,647 | −0.05% | plan? |
| Sep 18, 2018 SForm 4 → | Sep 20, 4:50 pm EDT | Zymeworks Inc.ZYME | 6,870 | $14.56 | $100,027 | 3,850,674 | −0.18% | plan? |
| Sep 14, 2018 SForm 4 → | Sep 18, 7:30 pm EDT | Zymeworks Inc.ZYME | 15,874 | $14.58 | $231,443 | 3,857,544 | −0.41% | plan? |
| Sep 12, 2018 SForm 4 → | Sep 14, 3:34 pm EDT | Zymeworks Inc.ZYME | 30,959 | $14.49 | $448,463 | 3,873,418 | −0.79% | plan? |
| Sep 10, 2018 SForm 4 → | Sep 12, 4:39 pm EDT | Zymeworks Inc.ZYME | 15,777 | $14.75 | $232,669 | 3,904,377 | −0.40% | plan? |
| Aug 31, 2018 SForm 4 → | Sep 4, 3:38 pm EDT | Zymeworks Inc.ZYME | 700 | $14.26 | $9,982 | 3,920,154 | −0.02% | plan? |
| Aug 29, 2018 SForm 4 → | Aug 31, 12:40 pm EDT | Zymeworks Inc.ZYME | 5,752 | $14.31 | $82,333 | 3,920,854 | −0.15% | plan? |
| Aug 14, 2018 SForm 4 → | Aug 16, 3:34 pm EDT | Zymeworks Inc.ZYME | 3,000 | $14.28 | $42,840 | 3,926,606 | −0.08% | plan? |
| Aug 10, 2018 SForm 4 → | Aug 14, 5:04 pm EDT | Zymeworks Inc.ZYME | 6,429 | $14.32 | $92,033 | 3,929,606 | −0.16% | plan? |
| Aug 3, 2018 SForm 4 → | Aug 7, 3:16 pm EDT | Zymeworks Inc.ZYME | 1,650 | $13.55 | $22,358 | 3,936,035 | −0.04% | plan? |
| Aug 2, 2018 SForm 4 → | Aug 3, 3:53 pm EDT | Zymeworks Inc.ZYME | 19,400 | $13.31 | $258,214 | 3,937,685 | −0.49% | plan? |
| Mar 1, 2017 JForm 4 → | Mar 1, 5:02 pm EST | CoLucid Pharmaceuticals, Inc.CLCD | 19,285,108 | $46.50 | $896,757,522 | 100 | — | plan? |
| Apr 12, 2016 CForm 4/A → | Apr 14, 7:35 pm EDT | Aeglea BioTherapeutics, Inc.AGLE | 2,010,924 | — | — | 2,068,543 | — | plan? |
| Apr 12, 2016 PForm 4 → | Apr 14, 6:41 pm EDT | Aeglea BioTherapeutics, Inc.AGLE | 500,000 | $10.00 | $5,000,000 | 2,568,543 | +24.2% | plan? |
| Apr 12, 2016 CForm 4 → | Apr 14, 6:41 pm EDT | Aeglea BioTherapeutics, Inc.AGLE | 2,010,924 | — | — | 2,068,543 | — | plan? |
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2018 AForm 4 → | Aug 13, 5:30 pm EDT | LEAP THERAPEUTICS, INC.LPTX | 331,221 | — | — | 331,221 | — | late |
| Apr 12, 2016 CForm 4 → | Apr 14, 6:41 pm EDT | Aeglea BioTherapeutics, Inc.AGLE | 2,010,924 | — | — | 0 | — |